Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Trial ID or NCT#

NCT00680992

Status

not recruiting iconNOT RECRUITING

Purpose

To determine how safe denosumab is in treating subjects with giant cell tumor of bone (GCTB)

Official Title

An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Eligibility Criteria

Ages Eligible for Study: Older than 12 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Kristen N Ganjoo
Kristen N Ganjoo
Sarcoma specialist, Medical oncologist
Professor of Medicine (Oncology)

Contact us to find out if this trial is right for you.

Contact

Cancer clinical Trials Office
650-498-7061

View on ClinicalTrials.gov